Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank 薬物名(臨床試験情報から抽出) KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 Biotin 1件: Biotin4件: BIOTIN; Biotina; D-BIOTIN; Vitamin B7; --5件: 2, 8, 10, 13, 20
2 Benzoic acid 1件: Benzoic acid1件: Benzoic acid; --1件: 51
3 Benzyl alcohol -0件: ---
4 Bacitracin -0件: ---
5 Baclofen 1件: Baclofen2件: Baclofen; Kemstro; 2件: GABBR1,
GABBR2 💬
7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬7件: 2, 10, 13, 18, 65, 149, 206
6 Benzonatate -0件: ---
7 Benzquinamide -0件: ---
8 Betamethasone 1件: Betamethasone1件: Betamethasone; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬7件: 2, 28, 46, 83, 90, 96, 235
9 Bisacodyl 1件: Bisacodyl1件: Bisacodyl; --1件: 13
10 Budesonide 1件: Budesonide4件: Budesonide; Entocort; Jorveza; Symbicort; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬9件: 66, 93, 94, 95, 96, 97, 98, 228, 299
11 Bumetanide 1件: Bumetanide1件: Bumetanide; 1件: SLC12A2 💬3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬2件: 6, 158
12 Busulfan 1件: Busulfan3件: Busilvex; Busulfan; BUSULFANO; --13件: 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326
13 Benzocaine -0件: ---
14 Buformin -0件: ---
15 Betaxolol hydrochloride -0件: ---
16 Benazepril hydrochloride 1件: Benazepril1件: Benazepril; 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬4件: 49, 57, 218, 224
17 Bepridil hydrochloride -0件: ---
18 Bisoprolol fumarate 1件: Bisoprolol2件: BISOPROLOL; Bisoprolol Fumarate; 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 67, 86, 113
19 Bretylium tosylate -0件: ---
20 Bendroflumethiazide 1件: Bendroflumethiazide1件: BENDROFLUMETHIAZIDE; --1件: 67
21 Benzthiazide -0件: ---
22 Brinzolamide -0件: ---
23 Brompheniramine maleate -0件: ---
24 Bitolterol mesylate -0件: ---
25 Beclomethasone dipropionate 1件: Beclomethasone dipropionate2件: Beclometasone dipropionate; Beclomethasone dipropionate; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 85, 97, 98
26 Buspirone hydrochloride 1件: Buspirone2件: Buspirone; Buspirone Hydrochloride; 2件: DRD2,
HTR1A 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬3件: 6, 51, 179
27 Bismuth subsalicylate -0件: ---
28 Butamben -0件: ---
29 Benztropine mesylate -0件: ---
30 Biperiden -0件: ---
31 Bromocriptine mesylate 1件: Bromocriptine1件: BROMOCRIPTINE; 2件: DRD2,
PRL 💬
12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 74
32 Botulinum toxin type A 1件: Botulinum toxin type A8件: BOTOX; Botulinum toxin A; BOTULINUM TOXIN TYPE A; BTX-A; Dysport; IncobotulinumtoxinA; OnabotulinumtoxinA; Xeomin; 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬13件: 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226
33 Bithionol -0件: ---
34 Bupropion hydrochloride 1件: Bupropion2件: Bupropion; Bupropion Hydrochloride; 2件: SLC6A2,
SLC6A3 💬
7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬5件: 8, 18, 21, 96, 171
35 Buprenorphine hydrochloride 1件: Buprenorphine1件: Buprenorphine; 2件: OPRK1,
OPRM1 💬
3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬3件: 46, 70, 298
36 Butorphanol tartrate -0件: ---
37 Butoconazole nitrate -0件: ---
38 Bicalutamide -0件: ---
39 Betamethasone sodium phosphate 1件: Betamethasone1件: Betamethasone; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬7件: 2, 28, 46, 83, 90, 96, 235
40 Bethanechol chloride 1件: Bethanechol1件: Bethanechol; 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 98
41 Benzbromarone 1件: Benzbromarone1件: BENZBROMARONE; --1件: 86
42 Biapenem -0件: ---
43 Boric acid -0件: ---
44 Butenafine hydrochloride -0件: ---
45 Bromperidol -0件: ---
46 Bucetin -0件: ---
47 Benzyl benzoate -0件: ---
48 Blonanserin -0件: ---
49 Betazole hydrochloride -0件: ---
50 Bisoxatin acetate -0件: ---
51 Bosentan 1件: Bosentan2件: Bosentan; Tracleer; 2件: EDNRA,
EDNRB 💬
9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
52 Bromazepam -0件: ---
53 Benfotiamine -0件: ---
54 Bufexamac -0件: ---
55 Bisibuthiamine -0件: ---
56 Bentiromide 1件: Bentiromide0件: --6件: 51, 89, 113, 117, 298, 299
57 Betamethasone valerate 1件: Betamethasone1件: Betamethasone; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬7件: 2, 28, 46, 83, 90, 96, 235
58 Bezafibrate 1件: Bezafibrate1件: BEZAFIBRATE; 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬7件: 20, 93, 94, 160, 296, 316, 324
59 Bromovalerylurea -0件: ---
60 Bismuth subgallate -0件: ---
61 Betamethasone acetate 1件: Betamethasone1件: Betamethasone; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬7件: 2, 28, 46, 83, 90, 96, 235
62 Benzyl nicotinate -0件: ---
63 Butyl parahydroxybenzoate -0件: ---
64 Bupivacaine hydrochloride 1件: Bupivacaine2件: Bupivacaine; BUPIVACAINE HYDROCHLORIDE; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬8件: 46, 51, 53, 70, 96, 168, 226, 298
65 Bronopol -0件: ---
66 Bendazac -0件: ---
67 Bethanidine sulfate -0件: ---
68 Betamethasone dipropionate 1件: Betamethasone1件: Betamethasone; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬7件: 2, 28, 46, 83, 90, 96, 235
69 Bismuth subnitrate -0件: ---
70 Bepotastine besylate -0件: ---
71 Bropirimine -0件: ---
72 beta-Butoxyethyl nicotinate -0件: ---
73 Barbital -0件: ---
74 Brotizolam -0件: ---
75 Bismuth subcarbonate -0件: ---
76 Broxuridine -0件: ---
77 Benoxinate hydrochloride 1件: Oxybuprocaine1件: Oxybuprocaine; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6
78 Bifonazole -0件: ---
79 Bucillamine 1件: Bucillamine1件: Bucillamine; --1件: 46
80 Benziodarone -0件: ---
81 Bemegride -0件: ---
82 Betamethasone butyrate propionate 1件: Betamethasone1件: Betamethasone; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬7件: 2, 28, 46, 83, 90, 96, 235
83 Barium sulfate -0件: ---
84 Brimonidine tartrate 1件: Brimonidine2件: Brimonidine; Brimonidine Tartrate; 3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬2件: 13, 90
85 Buclizine hydrochloride -0件: ---
86 Bleomycin sulfate 1件: Bleomycin1件: Bleomycin; --4件: 96, 278, 279, 280
87 Biperiden hydrochloride -0件: ---
88 Biperiden lactate -0件: ---
89 Betamethasone benzoate 1件: Betamethasone1件: Betamethasone; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬7件: 2, 28, 46, 83, 90, 96, 235
90 Benzylpenicillin 1件: Benzylpenicillin0件: --1件: 46
91 Bisoprolol 1件: Bisoprolol2件: BISOPROLOL; Bisoprolol Fumarate; 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 67, 86, 113
92 Betadex 1件: Betadex1件: Beta-cyclodextrin; --1件: 19
93 Benznidazole 1件: Benznidazole1件: Benznidazole; --1件: 65
94 Brofaromine -0件: ---
95 Butobarbital -0件: ---
96 Benperidol -0件: ---
97 Butaperazine -0件: ---
98 Balsalazide disodium 1件: Balsalazide3件: 2-Hydroxybenzoic acid; Balsalazide; Balsalazide Disodium; --1件: 97
99 Beraprost 1件: Beraprost1件: Beraprost; 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
100 Bimatoprost -0件: ---
101 Bacitracin methylenedisalicylate -0件: ---
102 Bacitracin zinc -0件: ---
103 Bambermycins -0件: ---
104 Basifungin -0件: ---
105 Basiliximab 1件: Basiliximab2件: Basiliximab; Simulect; 1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬6件: 2, 50, 66, 97, 222, 228
106 Batimastat -0件: ---
107 BCG vaccine 1件: BCG vaccine0件: --1件: 299
108 Becaplermin -0件: ---
109 Bectumomab -0件: ---
110 Belimumab 1件: Belimumab2件: BELIMUMAB; BENLYSTA; 1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬12件: 11, 13, 43, 44, 46, 49, 51, 53, 66, 222, 296, 300
111 Belladonna -0件: ---
112 Benazeprilat -0件: ---
113 Benoxaprofen -0件: ---
114 Benserazide 1件: Benserazide1件: BENSERAZIDE; 1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
115 Bentazepam -0件: ---
116 Bentonite -0件: ---
117 Bentoquatam -0件: ---
118 Benzoin -0件: ---
119 Benzoyl peroxide -0件: ---
120 Benzylpenicilloyl polylysine -0件: ---
121 Beractant -0件: ---
122 beta Carotene 1件: Beta carotene3件: Beta carotene; Beta-Carotene; BETACAROTENE; --2件: 13, 96
123 Betiatide -0件: ---
124 Bexarotene 1件: Bexarotene2件: Bexarotene; Targretin; 3件: RXRA,
RXRB,
RXRG 💬
17件: Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬2件: 13, 75
125 Bindarit -0件: ---
126 Binetrakin 1件: Binetrakin1件: Interleukin 4; 1件: IL4 💬16件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Leishmaniasis, PI3K-Akt signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 46
127 Binodenoson -0件: ---
128 Bivalirudin -0件: ---
129 Bizelesin -0件: ---
130 Bolasterone -0件: ---
131 Boldenone undecylenate -0件: ---
132 Bortezomib 1件: Bortezomib3件: BORTEZOMIB; Bortezomib Accord; Velcade; 1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬16件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 228, 256, 283, 288, 331
133 Brinolase -0件: ---
134 Bromelains -0件: ---
135 Bromfenac sodium -0件: ---
136 Bromocriptine 1件: Bromocriptine1件: BROMOCRIPTINE; 2件: DRD2,
PRL 💬
12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 74
137 Bromodiphenhydramine hydrochloride -0件: ---
138 Buquinolate -0件: ---
139 Butabarbital -0件: ---
140 Butalbital -0件: ---
141 Buthiazide -0件: ---
142 Butonate -0件: ---
143 Butorphanol -0件: ---
144 Butyl alcohol -0件: ---
145 Becatecarin -0件: ---
146 Belatacept 1件: Belatacept2件: Belatacept; Nulojix; 2件: CD80,
CD86 💬
12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬1件: 46
147 Bemotrizinol -0件: ---
148 Bleomycin hydrochloride 1件: Bleomycin1件: Bleomycin; --4件: 96, 278, 279, 280
149 Bisoctrizole -0件: ---
150 Bosutinib 1件: Bosutinib1件: BOSUTINIB; 2件: ABL1,
SRC 💬
49件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬2件: 2, 67
151 Brecanavir -0件: ---
152 Batroxobin -0件: ---
153 Bevacizumab 1件: Bevacizumab2件: AVASTIN; BEVACIZUMAB; 1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬9件: 13, 34, 85, 86, 87, 89, 227, 280, 331
154 Batabulin -0件: ---
155 Bavituximab -0件: ---
156 Bifeprunox -0件: ---
157 Bremelanotide -0件: ---
158 Bromopride -0件: ---
159 Broxyquinoline -0件: ---
160 Buprenorphine 1件: Buprenorphine1件: Buprenorphine; 2件: OPRK1,
OPRM1 💬
3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬3件: 46, 70, 298
161 Bietaserpine -0件: ---
162 Buflomedil -0件: ---
163 Butalamine -0件: ---
164 Benfluorex -0件: ---
165 Bamipine -0件: ---
166 Brodimoprim -0件: ---
167 Brivudine -0件: ---
168 Buserelin -0件: ---
169 Bumadizone -0件: ---
170 Butanilicaine -0件: ---
171 Bezitramide -0件: ---
172 Benorilate -0件: ---
173 Barbexaclone -0件: ---
174 Beclamide -0件: ---
175 Bornaprine -0件: ---
176 Budipine -0件: ---
177 Bambuterol -0件: ---
178 Bibrocathol -0件: ---
179 Bunaftine -0件: ---
180 Bacampicillin -0件: ---
181 Balsalazide 1件: Balsalazide3件: 2-Hydroxybenzoic acid; Balsalazide; Balsalazide Disodium; --1件: 97
182 Bambuterol hydrochloride -0件: ---
183 Bamethan -0件: ---
184 Bamifylline -0件: ---
185 Barnidipine -0件: ---
186 Beclometasone 1件: Beclomethasone dipropionate2件: Beclometasone dipropionate; Beclomethasone dipropionate; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 85, 97, 98
187 Befunolol -0件: ---
188 Bekanamycin 1件: Kanamycin1件: Kanamycin; --2件: 96, 291
189 Benactyzine -0件: ---
190 Benazepril 1件: Benazepril1件: Benazepril; 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬4件: 49, 57, 218, 224
191 Bencyclane -0件: ---
192 Bendamustine 1件: Bendamustine2件: Bendamustine; BENDAMUSTINE HYDROCHLORIDE; --2件: 28, 61
193 Benidipine -0件: ---
194 Benzatropine -0件: ---
195 Benproperine -0件: ---
196 Benzfetamine -0件: ---
197 Benzydamine -0件: ---
198 Benzyl hydroxybenzoate -0件: ---
199 Benzylthiouracil -0件: ---
200 Bepridil -0件: ---
201 Bergaptene -0件: ---
202 Betahistine -0件: ---
203 Betaine 1件: Betaine1件: Betaine; --2件: 201, 337
204 Betaxolol -0件: ---
205 Bifemelane -0件: ---
206 Bioallethrin -0件: ---
207 Bisoxatin -0件: ---
208 Bitolterol -0件: ---
209 Bleomycin 1件: Bleomycin1件: Bleomycin; --4件: 96, 278, 279, 280
210 Boldenone -0件: ---
211 Bopindolol -0件: ---
212 Bosentan 1件: Bosentan2件: Bosentan; TRACLEER; 2件: EDNRA,
EDNRB 💬
9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
213 Brimonidine 1件: Brimonidine2件: Brimonidine; Brimonidine Tartrate; 3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬2件: 13, 90
214 Bromfenac -0件: ---
215 Bromhexine -0件: ---
216 Brompheniramine -0件: ---
217 Brovanexine -0件: ---
218 Bucladesine 1件: Bucladesine1件: Bucladesine; 16件: PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬
18件: Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 246
219 Buclizine -0件: ---
220 Bunazosin -0件: ---
221 Bupivacaine 1件: Bupivacaine2件: Bupivacaine; BUPIVACAINE HYDROCHLORIDE; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬8件: 46, 51, 53, 70, 96, 168, 226, 298
222 beta-Alanine 1件: beta-Alanine1件: Beta-Alanine; --1件: 13
223 Bupranolol -0件: ---
224 Bupropion 1件: Bupropion2件: Bupropion; Bupropion Hydrochloride; 2件: SLC6A2,
SLC6A3 💬
7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬5件: 8, 18, 21, 96, 171
225 Buspirone 1件: Buspirone2件: Buspirone; Buspirone Hydrochloride; 2件: DRD2,
HTR1A 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬3件: 6, 51, 179
226 Butamirate -0件: ---
227 Butenafine -0件: ---
228 Butoconazole -0件: ---
229 Butriptyline -0件: ---
230 Bupropion hydrobromide 1件: Bupropion2件: Bupropion; Bupropion Hydrochloride; 2件: SLC6A2,
SLC6A3 💬
7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬5件: 8, 18, 21, 96, 171
231 beta-Sitosterol 1件: beta-Sitosterol1件: Sitosterol; --1件: 260
232 Baminercept 1件: Baminercept2件: Baminercept; Baminercept alfa; 1件: LTB 💬3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬4件: 13, 46, 53, 97
233 Bapineuzumab -0件: ---
234 Becocalcidiol -0件: ---
235 Begacestat -0件: ---
236 Belinostat -0件: ---
237 Betrixaban -0件: ---
238 Boceprevir -0件: ---
239 Brivanib alaninate -0件: ---
240 Brivaracetam 1件: Brivaracetam1件: BRIVARACETAM; 1件: SV2A 💬1件: ECM-receptor interaction 💬2件: 149, 309
241 Blinatumomab -0件: ---
242 Bilastine -0件: ---
243 Balapiravir -0件: ---
244 Bardoxolone 1件: Bardoxolone1件: Bardoxolone; --7件: 66, 67, 84, 85, 86, 218, 222
245 Bardoxolone methyl 1件: Bardoxolone methyl1件: BARDOXOLONE METHYL; --7件: 66, 67, 84, 85, 86, 218, 222
246 Bixalomer -0件: ---
247 Brentuximab vedotin 1件: Brentuximab vedotin2件: Brentuximab; Brentuximab Vedotin; 10件: TNFRSF8,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬
11件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬2件: 49, 51
248 Briakinumab -0件: ---
249 Brivanib -0件: ---
250 Budiodarone -0件: ---
251 Bepotastine -0件: ---
252 Bismuth subcitrate potassium -0件: ---
253 Bornyl acetate -0件: ---
254 Bavisant 1件: Bavisant1件: Bavisant; 1件: HRH3 💬1件: Neuroactive ligand-receptor interaction 💬1件: 6
255 Bedaquiline -0件: ---
256 Benralizumab 1件: Benralizumab2件: Benralizumab; Fasenra; 1件: IL5RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299
257 Brodalumab 1件: Brodalumab1件: Brodalumab; 1件: IL17RA 💬3件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway 💬2件: 37, 51
258 Blosozumab -0件: ---
259 Bitopertin -0件: ---
260 Bafetinib -0件: ---
261 Baricitinib 1件: Baricitinib2件: Baricitinib; OLUMIANT; 2件: JAK1,
JAK2 💬
35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬13件: 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325
262 Brexpiprazole -0件: ---
263 Balugrastim -0件: ---
264 Blisibimod 1件: Blisibimod1件: Blisibimod; --5件: 43, 44, 49, 63, 66
265 Bevenopran -0件: ---
266 Brilacidin -0件: ---
267 Birinapant -0件: ---
268 Bezlotoxumab 1件: Bezlotoxumab1件: Bezlotoxumab; --2件: 96, 97
269 Batefenterol -0件: ---
270 Brincidofovir -0件: ---
271 Buparlisib -0件: ---
272 Binimetinib 1件: Binimetinib1件: Binimetinib; 2件: MAP2K1,
MAP2K2 💬
89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34
273 Beclabuvir -0件: ---
274 Benzhydrocodone -0件: ---
275 Bradanicline -0件: ---
276 Briciclib -0件: ---
277 Bimagrumab 1件: Bimagrumab1件: Bimagrumab; 2件: ACVR2A,
ACVR2B 💬
4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 15
278 Bococizumab -0件: ---
279 Bempedoic acid -0件: ---
280 Butylene glycol 1件: Butylene glycol0件: --2件: 28, 46
281 Brilliant blue G -0件: ---
282 Besilesomab -0件: ---
283 Basmisanil -0件: ---
284 Basimglurant 1件: Basimglurant1件: Basimglurant; --1件: 158
285 Bexagliflozin -0件: ---
286 Brigatinib 1件: Brigatinib1件: Brigatinib; 1件: ALK 💬3件: Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer 💬1件: 34
287 Bictegravir -0件: ---
288 Birabresib -0件: ---
289 Brazikumab 1件: Brazikumab1件: BRAZIKUMAB; 1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97
290 Burosumab 1件: Burosumab1件: Burosumab; 1件: FGF23 💬11件: Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬1件: 238
291 Baloxavir marboxil -0件: ---
292 Brolucizumab -0件: ---
293 Berzosertib -0件: ---
294 Brexanolone 1件: Brexanolone1件: Allopregnanolone; 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 205
295 Biropepimut-S -0件: ---
296 Brontictuzumab -0件: ---
297 Balipodect -0件: ---
298 Bermekimab 1件: Bermekimab1件: BERMEKIMAB; 1件: IL1A 💬21件: AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus 💬1件: 51
299 Baloxavir -0件: ---
300 Brivoligide -0件: ---
301 Bleselumab 1件: Bleselumab1件: Bleselumab; 1件: CD40 💬17件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬1件: 222
302 Birtamimab 1件: Birtamimab1件: BIRTAMIMAB; --1件: 28
303 Blarcamesine 1件: Blarcamesine1件: Blarcamesine; 6件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
SIGMAR1 💬
14件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 156
304 Bemcentinib -0件: ---
305 Bimiralisib -0件: ---
306 Balovaptan -0件: ---
307 Branebrutinib 1件: Branebrutinib2件: BMS-986195; Branebrutinib; 1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬3件: 46, 49, 53
308 Belapectin -0件: ---
309 Bimekizumab 1件: Bimekizumab1件: BIMEKIZUMAB; 2件: IL17A,
IL17F 💬
6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬3件: 46, 97, 271
310 Belantamab mafodotin 1件: Belantamab mafodotin1件: Belantamab mafodotin; 10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬
12件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 28
311 Budigalimab -0件: ---
312 Bempegaldesleukin -0件: ---
313 Berotralstat -0件: ---
314 Bentracimab -0件: ---
315 Belumosudil 1件: Belumosudil1件: Belumosudil; 1件: ROCK2 💬21件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51
316 Balstilimab -0件: ---
317 Bulevirtide -0件: ---
318 Brexucabtagene autoleucel -0件: ---
319 Bintrafusp alfa -0件: ---
320 Beinaglutide -0件: ---
321 Bamlanivimab -0件: ---
322 Belzutifan -0件: ---
323 Batoclimab -0件: ---
324 Bergamot oil -0件: ---
325 Brensocatib 1件: Brensocatib1件: Brensocatib; 1件: CTSC 💬2件: Apoptosis, Lysosome 💬1件: 299
326 Balixafortide -0件: ---